Our consumer is always first: We listen, display compassion, and are thoughtful. We are approachable, friendly, and helpful. We believe in simplicity. We innovate. We invent and deploy technology creatively. We are data-informed and insight focused.
The "Valley of Death" is just a box with no exit. We built the door. In Pharma, 90% of the genius happens in the lab. But 90% of the failure happens on the way to the shelf. At MED, we don’t R&D new molecules. We R&D the pathway to market. We’ve heard the advice to "think outside the box" to disrupt healthcare. But when you’re dealing with the FDA, Patient Data Privacy, and complex supply chains, "outside the box" is where products go to die in regulatory limbo. We Think Insi
A new blueprint for unlocking drug adoption in emerging markets Pharma companies or Sponsor Clients entering Emerging Asia Pacific face the same persistent challenge: patients want treatment, hospitals want to provide it, but affordability blocks the pathway . Yet despite the scale of the problem, market-access implementation has barely changed in decades. Programs remain: Slow to localize Fragmented across agencies Dependent on manual assessment High-risk in terms of complia
Our team at PSMO 39th Annual Convention Last week, Medscore had the honor of attending the Philippine Society of Medical Oncology (PSMO) Convention 2025 held in the Philippines. One of the region’s leading annual gatherings of oncologists, researchers and healthcare professionals across Southeast Asia to share ideas about the future of cancer care. With the theme “𝑷𝑺𝑴𝑶 𝒂𝒕 𝒕𝒉𝒆 𝑯.𝑬.𝑨.𝑹.𝑻.” (Healthcare, Education, Access, Research & Transformation), this year’s c
